Woodline Partners »

Aeglea Biotherapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $8.2M 353k 23.28
2024-09-30 $7.8M 264k 29.41
2024-06-30 $6.2M 263k 23.51
2024-03-31 $3.8M 101k 37.93